Nova Biomedical to Host Webinar on COVID-19 Bedside Glucose Management
Risk of Ascorbic Acid and Hematocrit Interference That Can Elevate Glucose Meter Results
By: Nova Biomedical
Interest in the antioxidant properties of ascorbic acid use in critically ill patients is growing especially during the in the COVID-19 pandemic. As clinicians search for effective treatments for COVID-19, sepsis, and other critical illness, high dose ascorbic acid is widely considered. For these critically ill patients, severe anemia is also a common occurrence Unfortunately, most used hospital glucose meters have a substantial interference from ascorbic acid and anemia that radically elevates glucose meter results, leading to potential adverse events. This webinar examines the risk of inaccurate glucose meter results due to ascorbic acid and hematocrit interference and how hospitals can protect their patients against this threat.
The webinar will be delivered on three dates: Thursday, April 30th at 2:00 PM EST, Thursday, May 28th at 1:00 PM EST, and Thursday, June 18th at 4:00 PM EST. Attendees can earn educational credits for attending and can register online at novabiomedical.com/
About Nova Biomedical
Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of state-of-the-